Overview of autosomal dominant ataxias

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 389-398

  Subramony, S H ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961152960     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00024-3     Document Type: Chapter

References (63)

1. Behrends C., Langer C.A., Boteva R., et al. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers. Mol Cell 2006, 23:877-897.
2. Bennett E.J., Bence N.F., Jayakumar R., et al. Global impairment of the ubiquitin-proteasome system by nuclear or cytoplasmic protein aggregates precedes inclusion body formation. Mol Cell 2005, 17:351-365.
3. Bird T.D. Hereditary Ataxia Overview. GeneReviews 2008, Online. Available:. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=gene&part=ataxias.
4. Bowman A.B., Yoo S.Y., Dantuma N.P., et al. Neuronal dysfunction in a polyglutamine disease model occurs in the absence of ubiquitin-proteasome system impairment and inversely correlates with the degree of nuclear inclusion formation. Hum Mol Genet 2005, 14:679-691.
5. Brkanac Z., Fernandez M., Matsushita M., et al. Autosomal dominant sensory/motor neuropathy with ataxia (SMNA): linkage to chromosome 7q22-q32. Am J Med Genet 2002, 114:450-457.
6. Bulone D., Masino L., Thomas D.J., et al. The interplay between PolyQ and protein context delays aggregation by forming a reservoir of protofibrils. PLoS ONE 2006, 1:e111.
7. Cagnoli C., Mariotti C., Taroni F., et al. SCA28, a novel form of autosomal dominant cerebellar ataxia on chromosome 18p11.22-q11. Brain 2006, 129:235-242.
8. Charles P., Camuzat A., Benammar N., et al. French Parkinson's Disease Genetic Study Group. Are interrupted SCA2 CAG repeat expansions responsible for parkinsonism?. Neurology 2007, 69:1970-1975.
9. Chen D.H., Brkanac Z., Verlinde C.L., et al. Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am J Hum Genet 2003, 72:839-849.
10. Chung M., Lu Y.C., Cheng N.C., et al. A novel autosomal dominant spinocerebellar ataxia (SCA22) linked to chromosome 1p21-q23. Brain 2003, 126:1293-1299.
11. Di Bella D., Lazzaro F., Cagnoli C., et al. SCA28 2008, Abstract presented at AIM Meeting, Las Vegas.
12. Dickey C.A., Patterson C., Dickson D., et al. Brain CHIP: removing the culprits in neurodegenerative disease. Trends Mol Med 2007, 13:32-38.
13. Dudding T.E., Friend K., Schofield P.W., et al. Autosomal dominant congenital non-progressive ataxia overlaps with the SCA15 locus. Neurology 2004, 63:2288-2292.
14. Gatchel J.R., Zoghbi H.Y. Diseases of unstable repeat expansion: mechanisms and common principles. Genetics 2005, 6:743-755.
15. Gidalevitz T., Ben-Zvi A., Ho K.H., et al. Progressive disruption of cellular protein folding in models of polyglutamine diseases. Science 2006, 311:1471-1474.
16. Hara K., Shiga A., Nozaki H., et al. Total deletion and a missense mutation of ITPR1 in Japanese SCA15 families. Neurology 2008, 71:542-551.
17. Hara T., Nakamura K., Matsui M., et al. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 2006, 441:885-889.
18. Harding A.E. Classification of the hereditary ataxias and paraplegias. Lancet 1983, 1:1151-1155.
19. Harding A.E. The Hereditary Ataxias and Related Disorders 1984, Churchill Livingstone, Edinburgh.
20. Helmlinger D., Tora L., Devys D. Transcriptional alterations and chromatin remodeling in polyglutamine diseases. Trends Genet 2006, 22:562-570.
21. He Y., Zu T., Benzow K.A., et al. Targeted deletion of a single Sca8 ataxia locus allele in mice causes abnormal gait, progressive loss of motor coordination, and Purkinje cell dendritic deficits. J Neurosci 2006, 26:9975-9982.
22. Holmes S.E., O'Hearn E., Margolis R.L. Why is SCA 12 different from other SCAs?. Cytogenet Genome Res 2003, 100:189-197.
23. Houlden H., Johnson J., Garner-Thorpe C., et al. Mutations in TTBK2, encoding a kinase implicated in tau phosphorylation, segregate with spinocerebellar ataxia type 11. Nat Genet 2007, 39:1434-1436.
24. Ikeda Y., Dick K.A., Weatherspoon M.R., et al. Spectrin mutations cause spinocerebellar ataxia type 5. Nat Genet 2006, 38:184-190.
25. Iwaki A., Kawano Y., Miura S., et al. Heterozygous deletion of ITPR1, but not SUMF1, in spinocerebellar ataxia type 16. J Med Genet 2008, 45:32-35.
26. Jackson J.F., Currier R.D., Terasaki P.I., et al. Spinocerebellar ataxia and HLA linkage. N Engl J Med 1977, 296:1138-1141.
27. Jen J.C., Lee H., Cha Y.H., et al. Genetic heterogeneity of autosomal dominant nonprogressive congenital ataxia. Neurology 2006, 67:1704-1706.
28. Jen J.C., Graves T.D., Hess E.J., et al. Primary episodic ataxias: diagnosis, pathogenesis and treatment. Brain 2007, 130:2484-2493. CINCH investigators.
29. Knight M.A., Kennerson M.L., Anney R.J., et al. Spinocerebellar ataxia type 15 (SCA15) maps to 3p24.2-3pter: exclusion of the ITPR1 gene, the human orthologue of an ataxic mouse mutant. Neurobiol Dis 2003, 13:147-157.
30. Knight M.A., Garner R.J.M., Bahlo M., et al. Dominantly inherited ataxia and dysphonia with dentate calcification: spinocerebellar ataxia type 20. Brain 2004, 127:1172-1181.
31. Komatsu M., Waguri S., Chiba T., et al. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 2006, 441:880-884.
32. Lam Y.C., Bowman A.B., Jafar-Nejad P., et al. ATAXIN-1 interacts with the repressor capicua in its native complex to cause SCA1 neuropathology. Cell 2006, 127:1335-1347.
33. La Spada A.R., Fu Y.H., Sopher B.L., et al. Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron 2001, 31:913-927.
34. Lim J., Hao T., Shaw C., et al. A protein-protein interaction network for human inherited ataxias and disorders of Purkinje cell degeneration. Cell 2006, 125:801-814.
35. Lin X., Antalffy B., Kang D., et al. Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci 2000, 3:157-163.
36. Lorenzo D.N., Forrest S.M., Ikeda Y., et al. Spinocerebellar ataxia type 20 is genetically distinct from spinocerebellar ataxia 5. Neurology 2006, 67:2084-2085.
37. Moseley M.L., Zu T., Ikeda Y., et al. Bidirectional expression of CUG and CAG expansion transcripts and intranuclear polyglutamine inclusions in spinocerebellar ataxia type 8. Nat Genet 2006, 38:758-769.
38. Ogawa M. Pharmacological treatments of cerebellar ataxia. Cerebellum 2004, 3:107-111.
39. Okazawa H. Polyglutamine diseases: a transcription disorder?. Cell Mol Life Sci 2003, 60:1427-1439.
40. Perutz M.F., Johnson T., Suzuki M., et al. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc Natl Acad Sci U S A 1994, 91:5355-5358.
41. Pulst S.M., Santos N., Wang D., et al. Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset. Brain 2005, 128:2297-2303.
42. Schelhaas H.J., Ippel P.F., Hageman G., et al. Clinical and genetic analysis of a four-generation family with a distinct autosomal dominant cerebellar ataxia. J Neurol 2001, 248:113-120.
43. Schelhaas H.J., Verbeek D.S., Van de Warenburg B.P.C., et al. SCA19 and SCA22: evidence for one locus with a worldwide distribution [Letter]. Brain 2004, 127:e6.
44. Schols L., Bauer P., Schmidt T., et al. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004, 3:291-304.
45. Seki T., Takahashi H., Adachi N., et al. Aggregate formation of mutant protein kinase C gamma found in spinocerebellar ataxia type 14 impairs ubiquitin-proteasome system and induces endoplasmic reticulum stress. Eur J Neurosci 2007, 26:3126-3140.
46. Shao J., Diamond M.I. Polyglutamine diseases: emerging concepts in pathogenesis and therapy. Hum Mol Genet 2007, 16:R115-R123.
47. Simon D.K., Sheng K., Velazquez L., et al. Mitochondrial complex I gene variant associated with early age at onset in spinocerebellar ataxia type 2. Arch Neurol 2007, 64:1042-1044.
48. Soong B., Paulson H.L. Spinocerebellar ataxias: an update. Curr Opin Neurol 2007, 20:438-446.
49. Steffan J.S., Bodai L., Pallos J., et al. Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeration in Drosophila. Nature 2001, 413:739-743.
50. Stevanin G., Bouslam N., Thobois S., et al. Spinocerebellar ataxia with sensory neuropathy (SCA25) maps to chromosome 2p. Ann Neurol 2004, 55:97-104.
51. Storey E., du Sart D., Shaw J.H., et al. Frequency of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Australian patients with spinocerebellar ataxia. Am J Med Genet 2000, 95:351-357.
52. Tam S., Geller R., Spiess C., et al. The chaperonin TRiC controls polyglutamine aggregation and toxicity through subunit-specific interactions. Nat Cell Biol 2006, 8:1155-1162.
53. Van de Leemput J., Chandran J., Knight M.A., et al. Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet 2007, 3:1076-1082.
54. Van Swieten M.C., Brusse E., de Graaf B.M., et al. A mutation in the fibroblast growth factor 14 gene is associated with autosomal dominant cerebral (sic) ataxia. Am J Hum Genet 2003, 72:191-199.
55. Verbeek D.S., Van de Warenburg B.P., Wesseling P., et al. Mapping of the SCA23 locus involved in autosomal dominant cerebellar ataxia to chromosome region 20p13-12.3. Brain 2004, 127:2551-2557.
56. Verbeek D.S., Goedhart J., Bruinsma L., et al. PKC gamma mutations in spinocerebellar ataxia type 14 affect C1 domain accessibility and kinase activity leading to aberrant MAPK signaling. J Cell Sci 2008, 121:2339-2349.
57. Vuillaume I., Devos D., Schraen-Maschke S., et al. A new locus for spinocerebellar ataxia (SCA21) maps to chromosome 7p21.3-p15.1. Ann Neurol 2002, 52:666-670.
58. Warrick J.M., Morabito L.M., Bilen J., et al. Ataxin-3 suppresses polyglutamine neurodegeneration in Drosophila by a ubiquitin-associated mechanism. Mol Cell 2005, 18:37-48.
59. Watase K., Gatchel J.R., Sun Y., et al. Lithium therapy improves neurological function and hippocampal dendritic arborization in a spinocerebellar ataxia type 1 mouse model. PLoS Med 2007, 4:e182.
60. Waters M.F., Pulst S.M. SCA13. Cerebellum 2008, 7:165-169.
61. Williams A., Jahreiss L., Sarkar S., et al. Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications. Curr Top Dev Biol 2006, 76:89-101.
62. Xia H., Mao Q., Eliason S.L., et al. RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 2004, 10:816-820.
63. Ying M., Xu R., Wu X., et al. Sodium butyrate ameliorates histone hypoacetylation and neurodegenerative phenotypes in a mouse model for DRPLA. J Biol Chem 2006, 281:12580-12586.